Clinical Trial Update: Cancer Related Major Depression Treated With a Single Dose of Psilocybin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a single dose of psilocybin for cancer-related major depressive disorder, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Section for Affective Disorders; Northern Stockholm Psychiatry | Conditions: MDD | Phase 2 | Status: RECRUITING